Sam Corcos
Founder of Levels
Sam Corcos
Founder of Levels
New York, New York
Overview
Work Experience
Co-Founder, CEO
2019 - Current
Levels is an a16z-backed health tech company, here to help you see how food affects your health. By leveraging biosensors like continuous glucose monitors (CGM), Levels provides real-time feedback on how diet and lifestyle choices impact your metabolic health. Our Members are using personalized data to discover their optimal diet, control their weight, and reduce long-term health risk.
Founder, CTO (acquired Feb '20)
2016 - 2018
Y Combinator S17. CarDash is an automotive repair concierge service that makes car maintenance as painless as possible. I founded the company along with Yinon and Todd, built the original technology stack, and scaled up the engineering team. Built with a statically-hosted (CloudFront) React frontend using Redux and Apollo for state and data management. Backend built with Node, GraphQL, Apollo, and Serverless. Native app built with React Native, Redux, and Apollo.
Founder, CTO
2015 - 2017
At Sightline Maps, we built a system to 3D printing topographical maps primarily marketed to the US Military. We eventually expanded our functionality to include LiDAR data visualization and VR. Worked with Special Operations Command (SOCOM) to develop mapping technology under a Cooperative Research and Development Agreement (CRADA). Built with a mostly-serverless architecture with a statically-hosted frontend with React and S3/CloudFront, Phoenix and Python/Flask backend, and image processing handled by AWS Lambda.
Founder, Engineering Lead
2013 - 2015
Worked with a domain expert to built a better estimating software tool for the construction industry. The product focused on countertop fabricators to allow them to send more, accurate bids in a fraction of the time it took with contemporary methodology. Built with Meteor and Blaze.
Researcher
2005 - 2006
Two-year summer internship in the oncology department under Dr. Paul Gumerlock and Dr. Phil Mack. Co-author of "Sequence-dependent of apoptosis from green tea polyphenol, epigallocatechin-3-gallate (EGCG) plus cisplatin (CDDP) in non-small cell lung carcinoma (NSCLC) cells."
Investments
Latest Articles
How to Configure Your AWS Profile
Talks about AWS, Software Development and Configuration Management
License Plate Recognition in React Native
Talks about React Native, Programming and JavaScript
Strategies for Migrating a Phoenix App on Heroku
Talks about Phoenix Framework, Heroku and Ecto